Anbio Biotechnology

NNNN - CIK 0001982708

Market cap$1.50 B

Rank#2317

SEC filings40

NNNN balance sheet (annual)

The table below shows Anbio Biotechnology's balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024
Cash & equivalents	$7.77M	$11.76M
Short-term investments	$4.13M	-
Receivables	$3.66M	$1.06M
Inventory	-	-
Total current assets	$30.24M	$18.53M
Property, plant & equipment	-	-
Goodwill	-	-
Total assets	$30.24M	$18.92M
Accounts payable	$0.00	$1.63M
Total current liabilities

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.